Close

Hospitalization

CDC: Omicron Hospitalization Doubled in Unvaxxed Children

Unvaccinated children ages 5 to 11 were more than twice as likely to be hospitalized for COVID-19 during the Omicron wave, and nearly a third of hospitalized kids overall had no underlying medical conditions while about a fifth required intensive care unit (ICU) admission, researchers found. From Dec. 19, 2021 […]

Read More

Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022

Summary What is already known about this topic? Persons with previous SARS-CoV-2 infection have some protection against reinfection leading to hospitalization, but there is limited evidence regarding the additional benefit of vaccination among these persons. What is added by this report? Among persons with previous infection, COVID-19 mRNA vaccination provided […]

Read More

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19

Question  Among patients at risk of disease progression, does early treatment of mild to moderate COVID-19 with the neutralizing antibody sotrovimab prevent progression to severe disease? Findings  In this randomized clinical trial of 1057 participants, treatment with a single intravenous dose of sotrovimab, compared with placebo, resulted in a statistically significant reduction […]

Read More

COVID-19 Hospitalization Surge Among US Children Spurs New Omicron Concerns

Within weeks, the Omicron variant has fueled thousands of new COVID-19 hospitalizations among U.S. children, raising new concerns about how the many unvaccinated Americans under the age of 18 will fare in the new surge. The seven-day-average number of daily hospitalizations for children between Dec. 21 and Dec. 27 is […]

Read More

Rivaroxaban Safely Cuts VTE Risk After COVID-19 Hospitalization: MICHELLE

Extended anticoagulation with low-dose rivaroxaban (Xarelto, Bayer/Janssen) after hospitalization for COVID-19 may reduce the risk of venous thromboembolism (VTE) without worsening the risk of bleeding in patients who had been considered high-risk for VTE, a multicenter randomized trial suggests. The primary efficacy outcome occurred in five (3%) patients assigned to rivaroxaban and 15 (9%) […]

Read More

Rivaroxaban Safely Cuts VTE Risk After COVID-19 Hospitalization: MICHELLE

Extended anticoagulation with low-dose rivaroxaban (Xarelto, Bayer/Janssen) after hospitalization for COVID-19 may reduce the risk of venous thromboembolism (VTE) without worsening the risk of bleeding in patients who had been considered high-risk for VTE, a multicenter randomized trial suggests. The primary efficacy outcome occurred in five (3%) patients assigned to rivaroxaban and 15 (9%) […]

Read More

Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021

Summary What is already known about this topic? Persons aged 12–18 years are eligible to receive COVID-19 vaccine. Currently, data are lacking on real-world vaccine effectiveness against COVID-19 hospitalization in adolescents. What is added by this report? Among hospitalized U.S. patients aged 12–18 years, vaccine effectiveness of 2 doses of […]

Read More

Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021

Summary What is already known about this topic? Persons aged 12–18 years are eligible to receive COVID-19 vaccine. Currently, data are lacking on real-world vaccine effectiveness against COVID-19 hospitalization in adolescents. What is added by this report? Among hospitalized U.S. patients aged 12–18 years, vaccine effectiveness of 2 doses of […]

Read More

Remdesivir Sharply Cuts COVID Hospitalization Risk, Gilead Says

Remdesivir (Veklury, Gilead) was found to reduce some COVID-19 patients’ risk of hospitalization by 87% in a phase 3 trial, the drug’s manufacturer announced Wednesday in a press release. The randomized, double-blind, placebo-controlled trial evaluated the efficacy and safety of a 3-day course of intravenous remdesivir in an analysis of 562 nonhospitalized […]

Read More

Among the unvaccinated, delta variant more than doubles risk of hospitalization

New research from England’s public health service has confirmed a suspicion spawned by bursting hospital wards across the United States: The delta variant of the coronavirus not only spreads 50% more readily than the alpha variant it rapidly overtook, it’s also making unvaccinated people sicker. Through most of April and May, […]

Read More
Translate »